Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bloodthinners
bloodthinners
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Mon, 11/17/14 - 10:55 am
Eliquis
bloodthinners
Adexanet Alfa
Portola Pharmaceuticals
Pfizer
Bristol-Myers Squibb
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Fri, 10/31/14 - 02:01 pm
FDA
Daiichi Sankyo
advisory panels
bloodthinners
Savaysa
edoxaban
FDA staff recommends limited use of Daiichi's blood thinner
Yahoo/Reuters
Tue, 10/28/14 - 11:34 am
Daiichi Sankyo
FDA
bloodthinners
edoxaban
atrial fibrillation
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Motley Fool
Thu, 09/4/14 - 09:56 am
JNJ
Eliquis
Bristol-Myers Squibb
Xarelto
bloodthinners
Regado permanantly halts enrollment in lead drug trial
Yahoo/AP
Mon, 08/25/14 - 08:27 am
Regado Biosciences
clinical trials
Revolixys
bloodthinners
FDA approves Pfizer, Bristol-Myers' blood thinner for new indication against blood clots
Yahoo/AP
Thu, 08/21/14 - 04:03 pm
FDA
bloodthinners
Pfizer
Bristol-Myers Squibb
Eliquis
BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt
Fierce Pharma Marketing
Wed, 08/13/14 - 10:34 am
Pfizer
Eliquis
bloodthinners
Bristol-Myers Squibb
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thu, 06/19/14 - 10:36 am
NICE
Pradaxa
Xarelto
bloodthinners
Eliquis
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
Isis Pharma's experimental blood thinner succeeds in mid-stage trial
Yahoo/Reuters
Thu, 05/22/14 - 08:32 am
Isis Pharmaceuticals
bloodthinners
ISIS-FXIRx
Warfarin's Loss is Johnson & Johnson's Gain
Motley Fool
Mon, 04/21/14 - 04:20 pm
JNJ
bloodthinners
Warfarin
Pradaxa
Xarelto
Boehringer Ingelheim
Pfizer, Bristol-Myers announce results of subanalysis of Phase 3 ARISTOTLE trial
Yahoo/Fly on the Wall
Thu, 03/27/14 - 10:57 am
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Bristol-Myers reports positive results from Phase 3 ARISTOTLE trial
Yahoo/Fly on the Wall
Fri, 02/21/14 - 11:16 am
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Boehringer blood thinner lawsuits due to start in August
Yahoo/Reuters
Wed, 02/19/14 - 08:39 am
Boehringer Ingelheim
bloodthinners
Pradaxa
Boehringer facing more than 2,000 U.S. lawsuits over blood thinner
Yahoo/Reuters
Thu, 02/13/14 - 09:11 am
bloodthinners
Pradaxa
Boehringer Ingelheim
Johnson & Johnson: Third Time’s Not the Charm for Expanded Xarelto Approval
Wall St Cheat Sheet
Mon, 01/20/14 - 11:11 am
JNJ
Xarelto
bloodthinners
FDA
Merck's anti-blood clot drug should be approved -U.S. FDA staff
Yahoo/Reuters
Mon, 01/13/14 - 09:01 am
Merck
FDA
Vorapaxar
bloodthinners
FDA returns for look at risk of Boehringer Ingelheim's Pradaxa
Fierce Pharma
Mon, 01/6/14 - 04:53 pm
Pradaxa
FDA
Boehringer Ingelheim
bloodthinners
New Trial Confirms Role For Pradaxa In Venous Thromboembolism
Forbes
Wed, 12/18/13 - 10:48 am
Venous Thrombo-Embolism
Pradaxa
bloodthinners
Boehringer Ingelheim
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
Johnson & Johnson Vs. Pfizer, Bristol In The Race Of Anticoagulants
Seeking Alpha
Tue, 12/3/13 - 11:01 am
JNJ
bloodthinners
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »